E-LIB Suche - Ergebnisse für: Anaya, P.

1

EE95 Value Comparison of BACT/ALERT®; VIRTUO® System Versus..:

Krishnamurthy, P ; Anaya, P ; Bilir, SP...
Value in Health. 27 (2024) 6 - p. S75 , 2024

Link: https://doi.org/10.1016/..

2

Convolutional Neural Network Based Multi Class Classificati..:

, In: 2022 International Conference on Computer Communication and Informatics (ICCCI),

Suganthe, R.C. ; Latha, R.S. ; Geetha, M.... - p. 1-6 , 2022

Link: https://doi.org/10.1109/..

3

PCN47 Value of Driver Mutation Testing Strategies based on ..:

Liu, S. ; Shenolikar, R. ; Herrera-Restrepo, O...
Value in Health. 24 (2021) - p. S27 , 2021

Link: https://doi.org/10.1016/..

4

PUK7 COST-EFFECTIVENESS OF MIRABEGRON VERSUS ANTIMUSCARINIC..:

Ramos, B. ; Sánchez Trujillo, L.A. ; Walker, D..
Value in Health. 23 (2020) - p. S378 , 2020

Link: https://doi.org/10.1016/..

5

Determinación de la longitud de transferencia de alambres c..:

Anaya, P. ; Rodríguez, J. ; Andrade, C...
Informes de la Construcción. 72 (2020) 558 - p. 339 , 2020

Link: https://doi.org/10.3989/..

6

PCN129 A COST-UTILITY AND BUDGET IMPACT ANALYSIS OF ENZALUT..:

Toro, W. ; Braun, S. ; Sanchez, L.A..
Value in Health. 23 (2020) - p. S45-S46 , 2020

Link: https://doi.org/10.1016/..

7

CN4 ANÁLISIS DE COSTO-UTILIDAD E IMPACTO PRESUPUESTARIO DE ..:

Toro, W. ; Braun, S. ; Sanchez, L.A..
Value in Health Regional Issues. 19 (2019) - p. S4 , 2019

Link: https://doi.org/10.1016/..

8

PCN23 HODGKIN LYMPHOMA: FIRST INSTITUTIONAL AND ECUADORIAN ..:

Campoverde, F. ; Noboa, A. ; Posligua, K....
Value in Health. 22 (2019) - p. S60 , 2019

Link: https://doi.org/10.1016/..

9

Healthcare Resources Patterns and Cost Analysis of Pulmonar..:

Cerezo, O ; Guillen-López, C ; Rangel-Frausto, S..
Value in Health. 21 (2018) - p. S135-S136 , 2018

Link: https://doi.org/10.1016/..

10

Cost-Effectiveness of Treating Overactive Bladder With Mira..:

Ng, DB ; Parisé, H ; Dea, K...
Value in Health. 21 (2018) - p. S266-S267 , 2018

Link: https://doi.org/10.1016/..

11

A Cost-Effectiveness Analysis of Tacrolimus XL in Compariso..:

Anaya, P ; de Anda, JA ; Salazar, A.
Value in Health. 20 (2017) 9 - p. A896 , 2017

Link: https://doi.org/10.1016/..

12

The Cost-Effectiveness Of Delayed Release Dimethyl Fumarate..:

de Anda, JA ; Noda, C ; Anaya, P...
Value in Health. 19 (2016) 7 - p. A432 , 2016

Link: https://doi.org/10.1016/..

13

The Cost-Effectiveness Of Delayed-Release Dimethyl Fumarate..:

Noda, C ; de Anda, JA ; Anaya, P..
Value in Health. 19 (2016) 7 - p. A431 , 2016

Link: https://doi.org/10.1016/..

14

The Cost-Effectiveness of Bendamustine-Rituximab (Ben-R) Ve..:

Wehler, EA ; Kowal, S ; Ariza, JG...
Value in Health. 18 (2015) 7 - p. A818-A819 , 2015

Link: https://doi.org/10.1016/..

15

A Budget Impact Model Estimating the Financial Impact of In..:

Wehler, EA ; Kowal, S ; Obando, CA...
Value in Health. 18 (2015) 7 - p. A818 , 2015

Link: https://doi.org/10.1016/..